Trauma-induced coagulopathy (TIC) is a complex, multifactorial derangement of haemostasis that develops early after injury and significantly influences morbidity and mortality. Characterized by impaired coagulation, hyperfibrinolysis, endothelial dysfunction, platelet dysregulation, and systemic inflammation, TIC represents more than a by-product of severe trauma; it is a central pathophysiological driver of adverse outcomes. Early coagulopathy is strongly associated with increased transfusion requirements, higher incidence of acute respiratory distress syndrome, multiple organ failure, venous thromboembolism, and prolonged intensive care unit stays. In traumatic brain injury, TIC contributes to hematoma expansion, secondary neurological injury, and long-term cognitive and functional impairment. Despite advances in diagnostic modalities such as viscoelastic testing and biomarker based profiling, TIC remains under-recognized in many clinical settings, leading to delayed or suboptimal treatment. Evidence supports early haemostatic resuscitation, tranexamic acid administration, and goal-directed transfusion strategies as key interventions that improve outcomes. This chapter explores the clinical implications of TIC, highlighting its substantial impact on short- and long term outcomes. Understanding TIC and implementing timely, targeted interventions is essential to improving survival and recovery in severely injured patients.